Skip to main content
Premium Trial:

Request an Annual Quote

Timm-H. Jessen, Ian Taylor

Premium
Scienion this week announced the appointment of Timm-H. Jessen to the company’s supervisory board. Jessen was previously chief scientific officer of Evotec and held various positions at Hoechst, later Sanofi-Aventis.
 
Prior to joining Evotec, Jessen was a member of the international biotech integration team throughout the Hoechst merger with Roussel and Marion Merrell Dow, and was head of biotechnology for HMR Germany.
 

 
Cellexus Biosystems this week announced the appointment of Ian Taylor as commercial director.
 
Taylor previously held senior management positions at Genetix, PerkinElmer Life & Analytical Sciences, Genomic Solutions, PerSeptive Biosystems, and EG&G Wallac.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.